Aims and objectives
Various complications can occur after liver transplantation and these complications significantly affect the success of the surgery. Bile duct complications are one of the major causes of mortality and morbidity after liver transplantation, and the majority of them occur in the first six months. Risk factors for the development of bile duct complications include technical failure, T-tube or stent-related complications, hepatic artery thrombosis, hemorrhage, ischemia, or reperfusion injury as well as various immunological or infectious factors.
Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive imaging technique which does not require anesthesia and does not use ionizing radiation. It is commonly used to diagnose pancreatobiliary diseases, and today in many centers, it is the preferred method before Endoscopic Retrograde Cholangiopancreatography (ERCP). Besides the biliary tract it also gives information about liver parenchyma, neighboring soft tissues and organs.
Herein we aimed to present the MRCP findings of biliary tract complications after liver transplantation.
Methods and materials
85 patients who underwent MRCP in our department between July 2011-July 2015, after liver transplantation were retrospectively evaluated. Medical records of these patients were investigated from the database of our instution. Ten patients whose medical records were missing, whose follow-up period after MRCP was less than 12 months and who had insufficient MRCP images due to respiratory, motion or metallic artifacts were excluded from the study. A total of 75 patients were enrolled. There were 29 female, and 46 male patients with a mean age of 45 years. The type of biliary reconstruction was hepaticojejunostomy in 27 patients, and duct-to-duct anastomosis in 48 patients. T-tube insertion was performed in 10 of the 75 patients during the surgery.
MRCP was performed with a 1.5 Tesla MR device (Optima MR 450 W, GE) using phased array coils.
The MRCP images were re-evaluated by three radiologists in consensus. The diameter and morphology of the biliary ducts were assessed on MRCP images and anastomotic strictures, nonanastomotic strictures due to ischemic cholangitis, dilatation of the biliary ducts, filling defects due to stone or sludge, donor-to-recipient bile duct disproportion, biloma and other fluid collections were investigated. MRCP findings were evaluated together with clinical, radiological and laboratory findings in the follow-up period and were correlated with the final diagnosis. ERCP, percutaneous transhepatic cholangiography (PTC) and/or T tube cholangiography (TTC) were regarded as reference imaging methods.
Sensitivity, specificity, positive predictive and negative predictive values were calculated by comparing MRCP results with the final diagnosis.
Results
27 of the 75 patients had normal MRCP findings and at least one type of biliary tract complication was detected on MR images in 48 patients. These complications included anastomotic stricture (37.3%), dilatation of the biliary tract (48%), nonanastomotic stricture (5.3%), biliary leakage (6.7%), cholangitis (22.7%), biloma (10.7%), abscess due to cholangitis (8%), biliary stone-sludge (8%) and donor-to-recipient bile duct disproportion (6.7%) (figures 1-4) .
Thirty of the 75 patients were followed-up by clinical and laboratory findings for at least 12 months without further imaging. Thirty-five patients underwent ERCP, six patients underwent PTC, and four patients underwent TTC. MRCP findings were correlated with the findings of these examinations, which were considered as the reference imaging method, or with the final diagnosis depending on the clinical and laboratory findings during the follow-up period. No complications were diagnosed in 28 (37.3%) of these patients, and 47 patients (62.7%) had at least one bile duct complication. These complications included anastomotic stricture (38.7%), dilatation of the biliary tract (44%), nonanastomotic stricture (2.7%), biliary leakage (9.3%), cholangitis (18.7%), biloma (2.7%), abscess due to cholangitis (2.7%), biliary stone-sludge (8%) and donor-torecipient bile duct disproportion (3.4%).
MRCP had a sensitivity of 98% and specificity of 100% in demonstrating biliary tract complications. The positive predictive value was 100% and the negative predictive value was 75%.
